107 related articles for article (PubMed ID: 1306305)
21. Overexpression of c-Myc inhibits the appearance of a specific DNase I hypersensitive site in the beta-globin chromatin in murine erythroleukemia cells.
Takada S; Obinata M
Jpn J Cancer Res; 1991 Apr; 82(4):376-9. PubMed ID: 1904416
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells.
Kihara-Negishi F; Yamada T; Kubota Y; Kondoh N; Yamamoto H; Abe M; Shirai T; Hashimoto Y; Oikawa T
Int J Cancer; 1998 May; 76(4):523-30. PubMed ID: 9590129
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
24. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice.
Skoda RC; Tsai SF; Orkin SH; Leder P
J Exp Med; 1995 May; 181(5):1603-13. PubMed ID: 7722440
[TBL] [Abstract][Full Text] [Related]
25. A balance between self-renewal and commitment in the murine erythroleukemia cells with the transferred c-myc gene; an in vitro stochastic model.
Yamamoto T; Masuko K; Takada S; Kume TU; Obinata M
Cell Differ Dev; 1989 Nov; 28(2):129-33. PubMed ID: 2692787
[TBL] [Abstract][Full Text] [Related]
26. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
27. Genetic manipulation of RPS5 gene expression modulates the initiation of commitment of MEL cells to erythroid maturation: Implications in understanding ribosomopathies.
Vizirianakis IS; Papachristou ET; Andreadis P; Zopounidou E; Matragkou CN; Tsiftsoglou AS
Int J Oncol; 2015 Jul; 47(1):303-14. PubMed ID: 25998414
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
Chang TJ; Scher BM; Waxman S; Scher W
Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
[TBL] [Abstract][Full Text] [Related]
29. A novel system to identify Myb target promoters in friend murine erythroleukemia cells.
Chen J; Bender TP
Blood Cells Mol Dis; 2001; 27(2):429-36. PubMed ID: 11500057
[TBL] [Abstract][Full Text] [Related]
30. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
[TBL] [Abstract][Full Text] [Related]
31. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
[TBL] [Abstract][Full Text] [Related]
32. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
33. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
34. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
[TBL] [Abstract][Full Text] [Related]
35. Induction of transformed cells to terminal differentiation.
Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
[TBL] [Abstract][Full Text] [Related]
36. CP2 binding to the promoter is essential for the enhanced transcription of globin genes in erythroid cells.
Chae JH; Kim CG
Mol Cells; 2003 Feb; 15(1):40-7. PubMed ID: 12661759
[TBL] [Abstract][Full Text] [Related]
37. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
38. Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells.
Daishu H; Qing Z; Yehua G; Jianping Z; Jing M; Kequan C; Shepu X
Chin Med Sci J; 2002 Dec; 17(4):199-203. PubMed ID: 12901505
[TBL] [Abstract][Full Text] [Related]
39. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment.
Lachman HM; Hatton KS; Skoultchi AI; Schildkraut CL
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5323-7. PubMed ID: 3860863
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic factors involved in erythroid differentiation in mouse erythroleukemia (MEL) cells.
Watanabe T; Nomura S; Kaneko T; Yamagoe S; Kamiya T; Oishi M
Cell Differ Dev; 1988 Nov; 25 Suppl():105-9. PubMed ID: 3061584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
